The strategic alignment between a corporate social investor and its related company can mean greater social impact. But a close relationship can also jeopardise the ‘impact integrity’ of corporate social investors, as new research by EVPA shows.
Mologic seeks alternative to “relentless profiteering” of medical industry by providing affordable medical technology in poorer countries in £30m acquisition backed by Gates Foundation, Soros Economic Development Fund and others.
Social investors backing health and social care businesses see themselves as key partners – much more than just ‘bankers in sandals’ – as Covid-19 pressures refuse to abate. Catch up in the latest webinar from Pioneers Post and Good Finance.
C SUMMIT: Sanofi Espoir Foundation boss says the pandemic has confirmed its conviction that medicine and healthcare are not the full solution for global health challenges – while Repsol Foundation leader predicts a "time for doers".
How do social innovators turn crisis into opportunity? Three impact ventures share their experiences of adapting, pivoting and even expanding since the coronavirus outbreak.
The Ethiopian anaesthetist – who is providing the government with the country’s only advanced life support ambulances – on PPE challenges, facing possible bankruptcy, and why saving lives is non-negotiable.
A new wave of corporate social investors is drawing on the best of two worlds, philanthropy and corporate responsibility. A parent firm’s firepower brings advantages – but also challenges, as the Sanofi Espoir Foundation in France reveals.
Leading scientists at Imperial College London developing a Covid-19 vaccine have chosen a social enterprise structure for “maximum flexibility” and to remain affordable to the world’s poorest.
PLUS: Covid-19 announcements you may have missed; ADB Ventures tech fund raises first $50m; EU invests €1m in Oneplanetcrowd platform; grants for UK energy innovators; and more from the world of investing for good.
